XW-032

• Target :

  IDO|||Indoleamine 2,3-Dioxygenase (IDO)

• Related Pathways :

  Metabolism

• Bioactivity :

  XW-032 is an apo-IDO1 inhibitor with an IC50 of 21 nM. In the CT26 syngeneic mouse model, XW-032 demonstrates significant in vivo antitumor efficacy with a TGI of 63%, showing potential for cancer research applications.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C